Answer
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be life-threatening or fatal, have been reported in association with belimumab (Benlysta) treatment.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 35Document updated
Sources checked